Skip to content

Use of 5:2 fasting dietary plan in obese patients with type 2 diabetes: A pilot study

A randomised parallel pilot study to assess the tolerability and application of a 5:2 fasting dietary plan in obese patients with type 2 diabetes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000402640
Enrollment
40
Registered
2014-04-14
Start date
2014-04-14
Completion date
2014-09-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A pilot study to assess the safety and tolerability of a 5:2 diet for obese persons with type 2 diabetes.

Interventions

A 12 week dietary intervention where participants fast (reduction to 25% of normal calorie intake) on 2 days each week. The group will be randomised so that half fast on consecutive days each and the other half may chose any 2 days to fast within each 7 day period. The participants will be provided with example meal plans for fasting days but no food is provided in this study. Diet diaries are to be used at the start and end of the study period. A pre-defined medication adjustment protocol w

A 12 week dietary intervention where participants fast (reduction to 25% of normal calorie intake) on 2 days each week. The group will be randomised so that half fast on consecutive days each and the other half may chose any 2 days to fast within each 7 day period. The participants will be provided with example meal plans for fasting days but no food is provided in this study. Diet diaries are to be used at the start and end of the study period. A pre-defined medication adjustment protocol will be used to adjust glucose lowering medications on fasting days.

Sponsors

Endocrine, diabetes and research centre
Lead SponsorOther Collaborative groups

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

BMI 30 - 45 kg/m2 Type 2 diabetes treated with Metformin and/or a Sulphonylurea and/or insulin therapy HbA1c 64 – 86 mmol/mol

Exclusion criteria

Type 1 diabetes Known eating disorder Recent significant weight change (> 5 kg over past 3 months) Previous bariatric surgery Currently pregnant or planning pregnancy within 3 months Uncontrolled hypertension (180/100mmHg) Significant medical condition which, in the view of study investigators, would make recruitment in study inappropriate.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026